Skip to search.
 NZX 50 Down 0.29%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
5.29 Up 0.08(1.54%) 08:00
Prev Close:5.21
Open:5.27
Bid:5.21 x 100
Ask:5.50 x 400
1y Target Est:8.15
Beta:3.10174
Earnings Date:3 Aug - 8 Aug (Est.)
Day's Range:5.12 - 5.39
52wk Range:2.80 - 11.12
Volume:1,126,905
Avg Vol (3m):1,839,880
Market Cap:559.79m
P/E (ttm):N/A
EPS (ttm):-1.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXUp 1.54%559.79m
BAXUp 0.40%24.92b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):40.32
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.93
Quarterly EPS Est (Jun-16) :-0.27
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-0.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback